Bayesian Capital Management, LP Adma Biologics, Inc. Transaction History

Bayesian Capital Management, LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$5.98 - $11.18 $93,377 - $174,575	15,615 New	15,615 $174,000
Q4 2023 Feb 14, 2024	SELL	$3.08 - $4.52 $56,009 - $82,196	-18,185 Reduced 23.9%	57,915 $261,000
Q3 2023 Nov 14, 2023	BUY	$3.47 - $4.61 $264,067 - $350,821	76,100 New	76,100 $272,000
Q1 2023 May 15, 2023	SELL	$3.01 - $3.87 $92,870 - $119,404	-30,854 Reduced 73.46%	11,146 $36,000
Q4 2022 Feb 14, 2023	BUY	$2.47 - $3.88 $103,740 - $162,960	42,000 New	42,000 $162,000
Q2 2022 Aug 15, 2022	BUY	$1.43 - $2.2 $79,079 - $121,660	55,300 New	55,300 $109,000

317

185M

917K

91.6K

Ticker ADMA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 196,356,992
Market Cap $3.74B
Description
ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...

Get notified when there are updates to the investment portfolio of Bayesian Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Bayesian Capital Management, LP with notifications on news.